C. Hernandez

A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

P. Tariot, D. Arnold, R. Sperling, 2011, Neurology.

Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.

S. Targan, P. Rutgeerts, M. Spehlmann, 2007, Gastroenterology.

Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer’s disease clinical trials

Bruno Vellas, Michael Grundman, Sandrine Andrieu, 2013, Alzheimer's & Dementia.